Clinical efficacy and safety of subcutaneous rituximab in non-Hodgkin lymphoma: a systematic literature review and meta-analysis

Clinical efficacy and safety of subcutaneous rituximab in non-Hodgkin lymphoma: a systematic literature review and meta-analysis

ABSTRACTObjectives The role of subcutaneous (SC) rituximab in the efficacy and safety to non-Hodgkin lymphoma (NHL) is not clear enough. The purpose of this study was to conduct a systematic review and meta-analysis, to assess the efficacy and safety of subcutaneous rituximab to NHL.Method A full-sc...

Full description

Bibliographic Details
Main Authors: Tianyu Si, Xiaolin Ma, Wenwei Zhu, Yongming Zhou
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Hematology
Subjects:
Non-Hodgkin lymphoma
rituximab
subcutaneous
efficacy
safety
meta-analysis
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2023.2284047

Similar Items

Similar Items